Increased glyburide clearance in the pregnant mouse model

Drug Metabolism and Disposition

Volumn 38, Issue 9, 2010, Pages 1403-1406

  Zhou, Lin ^a,b   Zhang, Yi ^a,c   Hebert, Mary F ^a   Unadkat, Jashvant D ^a   Mao, Qingcheng ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A; GLIBENCLAMIDE; KETOCONAZOLE; S 9;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG INHIBITION; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PLASMA PROTEIN BINDING; PREGNANCY; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GLYBURIDE; HYPOGLYCEMIC AGENTS; MICE; PREGNANCY;

MUS;

EID: 77955989430     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.033837     Document Type: Article

References (17)

1. Bailer AJ (1988) Testing for the equality of area under the curves when using destructive measurement techniques. J Pharmacokinet Biopharm 16:303-309.
2. Golstein PE, Boom A, van Geffel J, Jacobs P, Masereel B, and Beauwens R (1999) Pglycoprotein inhibition by glibenclamide and related compounds. Pflugers Arch 437:652-660.
3. Hebert MF, Easterling TR, Kirby B, Carr DB, Buchanan ML, Rutherford T, Thummel KE, Fishbein DP, and Unadkat JD (2008) Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 84:248-253.
4. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, Caritis SN, Miodovnik M, Mattison DR, Unadkat JD, et al. (2009) Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 85:607-614.
5. Hickman D, Wang JP, Wang Y, and Unadkat JD (1998) Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metab Dispos 26:207-215.
6. Jönsson A, Rydberg T, Ekberg G, Hallengren B, and Melander A (1994) Slow elimination of glyburide in NIDDM subjects. Diabetes Care 17:142-145.
7. Langer O, Conway DL, Berkus MD, Xenakis EM, and Gonzales O (2000) A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343:1134-1138.
8. Lilja JJ, Niemi M, Fredrikson H, and Neuvonen PJ (2007) Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide. Br J Clin Pharmacol 63:732-740.
9. Mathias AA, Maggio-Price L, Lai Y, Gupta A, and Unadkat JD (2006) Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and Pglycoprotein. J Pharmacol Exp Ther 316:1202-1209.
10. Naritomi Y, Terashita S, and Kagayama A (2004) Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate. Xenobiotica 34:415-427.
11. Rowland M and Tozer T (1995) Elimination, in Clinical Pharmacokinetics: Concepts and Applications, 3rd ed, pp 165-168, Lippincott Williams & Wilkins, Philadelphia.
12. Satoh H, Yamashita F, Tsujimoto M, Murakami H, Koyabu N, Ohtani H, and Sawada Y (2005) Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 33:518-523.
13. Wang H, Wu X, Hudkins K, Mikheev A, Zhang H, Gupta A, Unadkat JD, and Mao Q (2006) Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am J Physiol Endocrinol Metab 291:E1295-E1304.
14. Zhang H, Wu X, Wang H, Mikheev AM, Mao Q, and Unadkat JD (2008) Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol Pharmacol 74:714-723.
15. Zharikova OL, Fokina VM, Nanovskaya TN, Hill RA, Mattison DR, Hankins GD, and Ahmed MS (2009) Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochem Pharmacol 78:1483-1490.
16. Zhou L, Naraharisetti SB, Liu L, Wang H, Lin YS, Isoherranen N, Unadkat JD, Hebert MF, and Mao Q (2010) Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharm Drug Dispos 31:228-242.
17. Zhou L, Naraharisetti SB, Wang H, Unadkat JD, Hebert MF, and Mao Q (2008) The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 73:949-959.